Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 mass balance, absolute bioavailability, and pharmacokinetics study of ASTX660 in healthy volunteers
NL-OMON49455Phase 1Completed
- Sponsor
- Astex Pharmaceuticals
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tolinapant, sponsored by Astex Pharmaceuticals. Primary endpoint: Mass balance and excretion pathways. Started Sep 2020; status: completed.
02
Drugs
tolinapant
Beyond the preview
Go deeper on NL-OMON49455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49455.